IVST (INNOVEST Global) Investment - first chapter
15 days ago
$IVST (INNOVEST Global) is up 2391% YTD and added $34
million sales run rate YTD through growth model of acquisitions.
Global) Investment is up 2391% YTD from $0.023 on zero revenue to 0.5500 on
$34 million revenue.
IVST Investment is
pleased to announce that the acquisition of Authority National Supply (ANS) is
closed. ANS was our sixth transaction to date, and has generated $22.8 million
in sales through the first three quarters of 2018. IVST now has approximately
55 employees and $34 million in annual run-rate revenue. $IVST Investment added $34 million sales run rate YTD through
growth model of acquisitions.
LOI on Pending Acquisition to add $12 Million in revenue.
CEO calls it "business as usual".
has ONLY 11.8M shares in the Float, unchanged for over two years. YES, NO new
shares are being issued!
IVSTInvestment has no convertible debts,
warrants, or options.
owns 20% of StemVax Therapeutics which is the first company in its Biotech Division.
IVST Investment has
the vision and model of Berkshire-Hathaway Holding
Company; we look forward to its evolution!